177 related articles for article (PubMed ID: 12438221)
1. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress in the protein-tyrosine phosphatase SHP1 gene: the significant correlation of the SHP1 gene silencing with the onset of lymphomas/leukemias].
Oka T; Ouchida M
Nihon Rinsho; 2003 Nov; 61(11):2025-32. PubMed ID: 14619449
[TBL] [Abstract][Full Text] [Related]
3. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
[TBL] [Abstract][Full Text] [Related]
5. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
Koyama M; Oka T; Ouchida M; Nakatani Y; Nishiuchi R; Yoshino T; Hayashi K; Akagi T; Seino Y
Lab Invest; 2003 Dec; 83(12):1849-58. PubMed ID: 14691303
[TBL] [Abstract][Full Text] [Related]
6. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
Oka T; Yoshino T; Hayashi K; Ohara N; Nakanishi T; Yamaai Y; Hiraki A; Sogawa CA; Kondo E; Teramoto N; Takahashi K; Tsuchiyama J; Akagi T
Am J Pathol; 2001 Oct; 159(4):1495-505. PubMed ID: 11583976
[TBL] [Abstract][Full Text] [Related]
7. Linking miRNA regulation to BCR-ABL expression: the next dimension.
Faber J; Gregory RI; Armstrong SA
Cancer Cell; 2008 Jun; 13(6):467-9. PubMed ID: 18538729
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
10. p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemia.
Matsuno N; Hoshino K; Nanri T; Kawakita T; Suzushima H; Kawano F; Mitsuya H; Asou N
Leuk Res; 2005 May; 29(5):557-64. PubMed ID: 15755508
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
Hayslip J; Montero A
Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression of MAGE-A3 gene in leukemia cells.
Martínez A; Olarte I; Mergold MA; Gutiérrez M; Rozen E; Collazo J; Amancio-Chassin O; Ordóñez RM; Montesinos JJ; Mayani H; McCurdy DK; Ostrosky-Wegman P; Garrido-Guerrero E; Miranda EI
Leuk Res; 2007 Jan; 31(1):33-7. PubMed ID: 16806467
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
Andersson A; Edén P; Lindgren D; Nilsson J; Lassen C; Heldrup J; Fontes M; Borg A; Mitelman F; Johansson B; Höglund M; Fioretos T
Leukemia; 2005 Jun; 19(6):1042-50. PubMed ID: 15843827
[TBL] [Abstract][Full Text] [Related]
15. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes.
Shivapurkar N; Takahashi T; Reddy J; Zheng Y; Stastny V; Collins R; Toyooka S; Suzuki M; Parikh G; Asplund S; Kroft SH; Timmons C; McKenna RW; Feng Z; Gazdar AF
Cancer Res; 2004 Jun; 64(11):3757-60. PubMed ID: 15172980
[TBL] [Abstract][Full Text] [Related]
16. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
[TBL] [Abstract][Full Text] [Related]
17. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
[TBL] [Abstract][Full Text] [Related]
18. Dual-specificity phosphatase Pyst2-L is constitutively highly expressed in myeloid leukemia and other malignant cells.
Levy-Nissenbaum O; Sagi-Assif O; Kapon D; Hantisteanu S; Burg T; Raanani P; Avigdor A; Ben-Bassat I; Witz IP
Oncogene; 2003 Oct; 22(48):7649-60. PubMed ID: 14576828
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
